Bromberg and Sunstein

Information may not be reliable

Abbott Laboratories v Syntron Bioresearch, Inc.
In a case involving immunoassay technology, we obtained a jury verdict of patent infringement and a permanent injunction on behalf of Abbott Laboratories.
Gates Formed-Fibre Products, Inc. v. Delaware Valley Corp.
By persuading a jury that the patents in suit were invalid, we successfully defended our client against accusations of infringement concerning a process for making fused-back automotive carpeting.
Comair Rotron, Inc. v Matsushita Electric Corp. of America
We obtained a $25 million jury verdict against industry giant Panasonic for willful infringement of our client Comair's patents on fans for electronic equipment.
Our successful advocacy extends to patent reexaminations and interferences

Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.
We took part in obtaining a $65 million jury verdict in a case involving the regulation of NFκ-B cell-signaling activity, the largest verdict in Massachusetts that year. A validity challenge led to reversal on appeal.
Comair Rotron v. Nippon Densan Corporation and Nidec Corporation
After securing a jury verdict of patent infringement, we negotiated a multimillion dollar settlement for our client Comair Rotron. The patent was directed to important magnetization technology for brushless DC electric motors.
B. Braun Medical, Inc. v. Abbott Laboratories
We obtained a jury verdict for Abbott Laboratories, defeating a $30 million patent infringement claim relating to intravenous valve devices.
In disputes over brand names, we have also delivered major successes to our clients.

Scientists at ArQule, a biotech client, are developing ARQ 197, which selectively blocks activity of an enzyme implicated in cancer cell growth and survival. This treatment is in Phase 2 clinical testing of patients with several types of solid tumors. With a corporate partner, ArQule recently announced plans to advance the compound to Phase 3 for the treatment of non-small cell lung cancer, which accounts for 28% of all cancer deaths. We obtained U.S. Patent No. 7,713,969 for ArQule's novel treatment for cancer.

Lisa Tittemore was recently honored by our pro bono client, GoodWeave USA, with a donor spotlight on its website. GoodWeave certifies child-labor-free rugs and rescues at-risk kids. More. . .

Sunstein attorneys overcome the rejection of patent claims in two recent cases.

Bruce Sunstein and Robert Asher will be listed in the Super Lawyers, Corporate Counsel Edition, 2010. The honor recognizes Bruce and Bob as intellectual property attorneys who have been listed in state and regional editions of Super Lawyers magazine.

After the Supreme Court's eBay decision (2006), it is harder to win injunctions against patent infringers. As Lisa Tittemore describes in the Federal Lawyer, judges are filling the remedy gap by awarding "ongoing royalties" to patentees, a controversial approach. More. . .

• Companies that participate in patent pools will not ordinarily be tagged for anticompetitive use of their patents. Princo v. ITC
• Examiners at the PTO follow new, patent-friendlier guidelines for determining the obviousness of an invention. More

• In a reversal regarding the first-sale doctrine, court says a software license can bar user from reselling the program. Vernor v. Autodesk